← Back to patent-cliff list
Levonorgestrel/Meloxicam (InnovaGyn)
Tier C — Watch / tradeLevonorgestrel/Meloxicam (InnovaGyn)
InnovaGyn Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PR, COX-2, COX-1
Indications (approved)：Labour and delivery
Regional status
US
Phase II
2022-06-28
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Levonorgestrel/Meloxicam (InnovaGyn)?
Approved indications include: Labour and delivery.
When does the Levonorgestrel/Meloxicam (InnovaGyn) patent expire?
No public expiry year is available for Levonorgestrel/Meloxicam (InnovaGyn) yet; this page updates once verified.
How do I get a quote for Levonorgestrel/Meloxicam (InnovaGyn) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05